According to the Cell paper, the type 1 diabetes patient "achieved sustained insulin independence" 75 days after the procedure took place.
The patient's time-in-target glycemic range increased from a baseline value of 43.18% to 96.21% by month 4 post-transplantation, accompanied by a decrease in glycated hemoglobin.
As for the patient, a 25-year-old woman - well, she's excited to enjoy some of her favorite foods again. "I enjoy eating everything - especially hotpot," she told Nature.
The team hopes to expand the trials to more people to get a better sense of its efficacy.
Collection
[
|
...
]